Veradermics SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 19, 2026, 9:06 a.m. ETView on SEC.gov
Regulation FD disclosure · Other events · Financial statements and exhibits
AI summary, unreviewedVeradermics (NYSE: MANE) Reports Positive Phase 3 Study 304 Topline: VDPHL01 Achieves 28.6 and 36.4 hairs/cm² TAHC Gains vs. 6.6 Placebo
8-KAug. 11, 2026, 8:15 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits